Sclerosis News and Research

RSS

Dr. Genova wins K18 award to advance research on transition-age youth with autism

Helen M. Genova, PhD, of Kessler Foundation, was awarded a two-year K18 grant for $266,988 from the NIH's National Institute of Mental Health - the NIMH Career Enhancement Award to Advance Autism Services Research for Adults and Transition-Age Youth.

28 Dec 2020

New therapeutic strategy designed to improve kidney function after lung transplantation

The Covid-19 pandemic shows the importance of medical research in the treatment of lung diseases. The Medical University of Vienna is renowned the world over in the field of lung transplantation medicine.

23 Dec 2020

FDA issues warning letters to companies illegally selling unapproved CBD products

Today, the U.S. Food and Drug Administration issued five warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).

22 Dec 2020

Researchers explore why seizures happen in a subset of MS patients

A research team at the University of California, Riverside School of Medicine has identified a pathway involving astrocytes, a class of central nervous system support cells, that could shed light on why seizures happen in a subset of multiple sclerosis, or MS, patients.

21 Dec 2020

Researchers demonstrate potential preventive treatment for Crohn's disease

A potential preventive treatment for Crohn's disease, a form of inflammatory bowel disease, has been demonstrated in a mouse model and using immune-reactive T cells from patients with Crohn's disease.

21 Dec 2020

A protein may be responsible for triggering lung scarring in scleroderma patients

Systemic sclerosis is an autoimmune disease associated with inflammation and fibrosis, or scarring, that affects organs including the skin, heart, kidney and lungs.

17 Dec 2020

Additional data demonstrates positive results of pridopidine drug on Total Functional Capacity

Positive results from additional analyses of PRIDE-HD and Open-HART trials with pridopidine published in a peer-reviewed journal, The Journal of Huntington's Disease.

17 Dec 2020

Pulmonary hypertension drug may become a treatment option for cancer

A drug used to treat pulmonary hypertension significantly reduced the capacity of tumor cells to migrate and invade other tissues in trials involving pancreatic, ovarian, breast cancer, and leukemia cell lines.

15 Dec 2020

Microglial surveillance helps prevent seizure activity in the brain

An important part of the brain's immune system, cells called microglia constantly extend and retract "branches" from their cell body to survey their environment.

14 Dec 2020

Compound derived from thunder god vine could improve outcomes for pancreatic cancer patients

The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute, an affiliate of City of Hope, suggest how a compound derived from the thunder god vine -- an herb used in China for centuries to treat joint pain, swelling and fever -- is able to kill cancer cells and potentially improve clinical outcomes for patients with pancreatic cancer.

14 Dec 2020

Researchers receive $651,997 funding to study memory dysfunction in MS

Researchers at Montclair State University and Kessler Foundation have received funding totaling $651,997 from the National Multiple Sclerosis Society to measure memory-related abilities in individuals with and without multiple sclerosis (MS) for clues to how such cognitive processes are altered by MS. Joshua Sandry, PhD, assistant professor of psychology at Montclair State and Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research at Kessler Foundation, collaborate on the 4-year study, titled "Neuroimaging of Hippocampally Mediated Memory Dysfunction in Multiple Sclerosis."

10 Dec 2020

Antiepileptic drug reduces early signs of clinical dysfunction in people with ALS

The antiepileptic drug ezogabine reduced pathologic excitability of cortical and spinal motor neuron cells that are early signs of clinical dysfunction in people with amyotrophic lateral sclerosis (ALS), according to a study conducted by the Neurological Clinical Research Institute of Massachusetts General Hospital.

10 Dec 2020

Study reveals new biomarker for amyotrophic lateral sclerosis

ALS is a fatal neurodegenerative disease causing a rapid loss of motor function, which usually results in a serious condition with early death within a few years.

9 Dec 2020

Study describes novel aging clock trained to predict human age

Deep Longevity, a Hong-Kong based longevity startup, has published their research on the epigenetics of aging in the Aging and Disease journal.

9 Dec 2020

Free radicals may be important for the brain to remain adaptable

Reactive oxygen molecules, also known as "free radicals", are generally considered harmful. However as it now turns out, they control cellular processes, which are important for the brain's ability to adapt - at least in mice.

5 Dec 2020

Lung tissue analysis reveals promising molecular target to ameliorate pulmonary fibrosis

An analysis of lung tissues from patients with different types of pulmonary fibrosis - including cases triggered by COVID-19 - has revealed a promising molecular target to ameliorate the chronic and irreversible disease.

5 Dec 2020

Study finds surprising link between ALS, FTD and Huntington's disease-associated mutation

A study led by researchers at the National Institutes of Health has made a surprising connection between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), two disorders of the nervous system, and the genetic mutation normally understood to cause Huntington's disease.

5 Dec 2020

Sclerosis News and Research

Dr. Genova wins K18 award to advance research on transition-age youth with autism

New therapeutic strategy designed to improve kidney function after lung transplantation

FDA issues warning letters to companies illegally selling unapproved CBD products

Researchers explore why seizures happen in a subset of MS patients

Researchers demonstrate potential preventive treatment for Crohn's disease

A protein may be responsible for triggering lung scarring in scleroderma patients

Additional data demonstrates positive results of pridopidine drug on Total Functional Capacity

Pulmonary hypertension drug may become a treatment option for cancer

Microglial surveillance helps prevent seizure activity in the brain

Compound derived from thunder god vine could improve outcomes for pancreatic cancer patients

Researchers receive $651,997 funding to study memory dysfunction in MS

Antiepileptic drug reduces early signs of clinical dysfunction in people with ALS

Study reveals new biomarker for amyotrophic lateral sclerosis

Study describes novel aging clock trained to predict human age

Free radicals may be important for the brain to remain adaptable

Lung tissue analysis reveals promising molecular target to ameliorate pulmonary fibrosis

Study finds surprising link between ALS, FTD and Huntington's disease-associated mutation

Research provides deeper insight into the pathogenesis of sclerodermatous chronic GVHD

Novel ALS study effectively visualizes neuroinflammation

Experimental drug can reverse age-related memory decline in mice

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News